Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial
Authors: Fehrenbacher, Louis | Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research | May 1, 2024 | PubMed abstract
